How Long After a Steroid Injection Can You Get a Flu Shot?

Most expert guidelines recommend waiting at least one week between a corticosteroid injection and a flu shot, in either direction. This buffer comes from a multisociety position statement endorsed by pain medicine and orthopedic organizations, which advises scheduling the steroid injection no sooner than one week before or one week after influenza vaccination. That said, the one-week window is a cautious recommendation rather than a hard rule, and the underlying evidence is more nuanced than a single number suggests.

What the Current Guidelines Recommend

The clearest guidance comes from a multisociety, multispecialty position statement published in Regional Anesthesia & Pain Medicine, which addresses both influenza and COVID-19 vaccine timing around corticosteroid injections. The recommendation is straightforward: for patients with non-urgent indications, corticosteroid injections should be offered at least one week before or one week after a flu vaccine dose.¹ The American Academy of Orthopaedic Surgeons issued a similar but slightly wider window specifically for COVID-19 vaccines, recommending two weeks before and one week after vaccine administration.²

An important caveat sits within these guidelines: for healthy patients, the injection or vaccine may be performed without the one-week interval after a discussion about the potential risk of reduced vaccine effectiveness.¹ In other words, if you are in significant pain and flu season is upon you, your doctor may reasonably decide that both the injection and the vaccine should proceed on whatever schedule works, with the understanding that the vaccine’s protection might be slightly blunted.

Why the One-Week Buffer Exists

Corticosteroids are powerful anti-inflammatory drugs, and part of how they reduce inflammation is by dialing down immune activity. When you receive a vaccine, your immune system needs to mount a response to the vaccine’s components in order to build protective antibodies. The concern is that a corticosteroid injection, even a local one into a joint or the spine, can temporarily suppress parts of the immune system and reduce how robustly your body responds to the vaccine.

Intra-articular corticosteroid injections have well-documented systemic effects beyond the joint itself, including temporary suppression of the body’s stress-hormone axis. Because of this suppression, there is at least a theoretical risk that a steroid injection could dampen the immune response to a vaccine given around the same time.² The one-week window is designed to let the most acute immunosuppressive effects of the steroid wear off before the vaccine arrives, or to let the vaccine’s initial immune response gain traction before the steroid enters the picture.

What the Research Actually Shows About Flu Vaccine Response

Here is where it gets interesting: the direct evidence that corticosteroids meaningfully reduce the flu vaccine’s effectiveness is surprisingly thin. Several studies have specifically looked at whether steroid use blunts antibody responses to influenza vaccination, and the findings are largely reassuring.

In elderly patients with chronic lung disease who were on long-term oral or inhaled corticosteroids, researchers found no significant differences in antibody responses to influenza vaccine compared with similar patients not receiving steroids. Antibody titers rose from baseline after vaccination in all groups, and seroprotection rates were comparable regardless of steroid use.³ A separate study examining an adjuvanted influenza vaccine in elderly patients with chronic lung disease reached the same conclusion: systemic steroids did not influence the antibody response.⁴

In children with asthma who were receiving short bursts of prednisone for flare-ups, the steroid treatment did not diminish their response to the influenza vaccine compared with controls. The researchers concluded that children can be effectively vaccinated against influenza while actively receiving prednisone therapy for asthma exacerbations.⁵

The multisociety position statement itself notes that investigators evaluating the effect of corticosteroids on influenza vaccine antibody titers did not observe differences between steroid-treated patients and control groups, and concluded that corticosteroids did not influence the antibody response to the flu vaccine.⁶ So the one-week recommendation is cautious guidance built more on theoretical concern and the general principle that immune suppression could blunt vaccine response, rather than on strong direct evidence that it actually does so for the flu shot specifically.

The Joint Injection Study That Raised a Red Flag

One study does stand out as concerning. A retrospective analysis covering five influenza seasons in Olmsted County, Minnesota, looked at over 15,000 major joint corticosteroid injections. Among vaccinated patients who also received a joint injection, there was roughly a 50 percent higher risk of developing influenza compared with vaccinated patients who did not receive a joint injection.⁷

That number sounds alarming, but it deserves context. The study was retrospective, meaning researchers looked backward at medical records rather than running a controlled experiment. Patients who get joint injections are not identical to patients who do not. The injection group had higher rates of autoimmune disorders, diabetes, and chronic lung disease, all of which independently increase infection risk.⁸ The American Society of Pain and Neuroscience has noted that relying on this kind of data to guide treatment decisions is scientifically questionable because of the confounding factors involved.

Still, the study is one of the few to directly examine real-world influenza outcomes rather than just antibody levels, and it contributed to the conservative one-week buffer in current guidelines. It is a data point, not a definitive answer, but it is the kind of data point that makes guideline writers cautious.

Does the Type of Steroid Injection Matter

Not all steroid injections carry the same level of concern, though the guidelines generally do not differentiate between them. The degree to which a corticosteroid injection suppresses immune function depends on several factors: the dose, the specific steroid used, and the injection site.

A knee or shoulder injection typically uses a moderate dose of a long-acting steroid like triamcinolone. These injections have documented systemic absorption, and the stress-hormone suppression they cause can last days to weeks. An epidural steroid injection, often used for back pain, also involves systemic absorption, but the clinical picture is different. The American Society of Pain and Neuroscience has noted that while epidural steroids may be absorbed systemically, the doses used and the way these injections behave in the body make it unlikely that they produce the kind of immune suppression seen with chronic, high-dose oral steroid use.⁸

The same source acknowledges a frustrating gap in the evidence: specific data on vaccine efficacy in the setting of local steroid injections are lacking. Most of the research on steroids and vaccine response involves oral steroids, inhaled steroids, or high-dose intravenous steroids used in cancer treatment. The localized injection scenario sits in a gray zone where the theoretical risk exists but the direct evidence is sparse.

Smaller injections, like those into a finger joint or a tendon sheath, probably have less systemic effect than a large joint injection, but there are no studies specifically teasing apart vaccine response by injection site. In practice, the one-week guideline is applied across all types of corticosteroid injections as a blanket precaution.

Lessons from COVID-19 Vaccine Research

The COVID-19 pandemic generated a burst of research on steroid-vaccine interactions that did not exist for flu vaccines. While the findings apply to a different vaccine, they shed light on the underlying biology in ways that are relevant here.

In cancer patients receiving chemotherapy with dexamethasone (a potent systemic corticosteroid), COVID-19 vaccine antibody levels were markedly lower compared with patients not receiving dexamethasone. The difference was substantial: median antibody titers were roughly three times lower in the steroid group. The lowest antibody levels were seen in patients who received the highest cumulative steroid doses and in those vaccinated on the same day they received dexamethasone.⁹

This study examined a very different scenario from a single joint injection in an otherwise healthy person. These were cancer patients receiving repeated high-dose systemic steroids as part of chemotherapy. But it reinforces the general principle: the dose and timing of steroids relative to vaccination matters, and same-day administration of high-dose steroids clearly can reduce vaccine effectiveness. The multisociety position statement references this kind of evidence when noting that corticosteroid injections may reduce the efficacy of COVID-19 vaccines.¹⁰

The takeaway is not that your knee injection will do the same thing as chemotherapy-level dexamethasone. It is that timing matters more when the steroid dose is high and the administration route is systemic. A local injection is a lower-risk scenario, but “lower risk” is not the same as “no risk,” and one week of separation costs most patients very little.

When You Cannot or Should Not Wait

Real life does not always cooperate with ideal timing windows. If you are in severe pain and your only available appointment for a steroid injection falls two days after your flu shot, or if flu season is peaking and you cannot delay vaccination by a week, it is worth knowing that the guidelines explicitly allow for flexibility.

The multisociety position statement makes clear that for healthy patients, the injection or the vaccine may be given without the one-week interval, provided the patient understands and accepts the possibility of reduced vaccine effectiveness.¹ Getting the flu shot with a slightly blunted response is better than skipping it entirely. A partially effective immune response still provides some protection, and the flu shot’s value lies partly in reducing the severity of illness even when it does not prevent infection altogether.

The situation calls for more caution if you are immunocompromised, elderly, or have conditions that already reduce your vaccine response. In those cases, squeezing in the one-week buffer becomes more worthwhile, because you are starting from a weaker immune baseline and any additional blunting matters more. Talk to your doctor about which takes priority given your specific health situation and the timing of flu season in your area.

Practical Scheduling Tips

If you know you need both a steroid injection and a flu shot in the same season, a little planning goes a long way. Here are some approaches that make the timing work:

Get the flu shot first: Schedule your flu vaccination at least one week before a planned steroid injection. This gives your immune system a head start on building antibodies before the steroid arrives.
Reverse the order if needed: If the injection has already happened, wait at least one week before getting your flu shot. Most of the acute systemic effects of a single joint injection subside within that window.
Coordinate with your providers: Your orthopedist or pain specialist and your primary care doctor may not automatically communicate about vaccine timing. Mention your upcoming injection at your flu shot appointment, or vice versa.
Do not skip the vaccine: If the timing is awkward and a one-week gap is not possible, getting both is still better than skipping the flu shot. The risk of a slightly blunted response is minor compared with the risk of unvaccinated influenza, particularly in older adults or people with chronic conditions.

Why the Evidence Gap Persists

You might wonder why, given how common both steroid injections and flu shots are, we do not have a definitive randomized trial answering this question once and for all. The practical barriers are significant. To run the ideal study, you would need to randomly assign patients to receive their flu shot at various intervals around a steroid injection and then track who gets influenza over the following months. The sample sizes required would be enormous, because influenza rates vary wildly by season, and most vaccinated people do not get the flu regardless of steroid timing.

The studies that do exist mostly measure antibody titers as a proxy for protection, which is useful but imperfect. Antibody levels tell you how your immune system responded to the vaccine, but they do not perfectly predict whether you will get sick. The Olmsted County study that tracked actual influenza cases is valuable precisely because it looked at the outcome that matters, though its retrospective design limited the conclusions it could draw.

This is a space where the evidence is unlikely to improve dramatically. Steroid injections and flu vaccines are both safe, widely used, and inexpensive. The potential interaction is modest enough that it does not threaten lives in large numbers, which makes it hard to justify the cost of a large randomized trial. The one-week recommendation is a reasonable hedge based on the biology of immune suppression, supported by limited but suggestive data, and it is probably the best guidance we will have for the foreseeable future.

Steroid Injections and Other Vaccines

The timing question extends beyond the flu shot. If you are scheduling a shingles vaccine, a pneumonia vaccine, or a COVID-19 booster alongside a steroid injection, similar principles apply. The multisociety position statement addresses COVID-19 vaccines with the same one-week recommendation used for influenza vaccines.¹ For other vaccines, there is even less specific guidance, but the underlying logic is the same: if a steroid can temporarily blunt immune responses, spacing it away from any vaccine is prudent when practical.

Live vaccines are a separate category worth mentioning. The flu shot given to most adults is an inactivated vaccine, meaning it does not contain live virus and cannot cause infection regardless of your immune status. The nasal-spray flu vaccine (FluMist) is a live attenuated vaccine, and immunosuppressed individuals are generally advised to avoid live vaccines altogether. If you are on high-dose steroids or other immunosuppressive medications, make sure you are receiving the injected flu shot rather than the nasal spray, regardless of timing.

For people on chronic immunosuppressive therapy, such as those with rheumatoid arthritis or organ transplants, the conversation about vaccine timing becomes more complex and should involve the specialist managing the immunosuppressive regimen. A single joint injection in an otherwise healthy person is a very different clinical scenario from ongoing biologic therapy or daily oral steroids, and the one-week buffer is generally sufficient for the former.

1
Regional Anesthesia & Pain Medicine. Multisociety multispecialty position statement on corticosteroid injections and influenza and COVID-19 vaccine administration
2
PubMed Central. The Effect of Intra-articular Corticosteroid Injections on Vaccine Efficacy: A Current Concepts Review
3
PubMed Central. Influence of corticosteroid therapy on the serum antibody response to influenza vaccine in elderly patients with chronic pulmonary diseases
4
PubMed. Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients
5
PubMed. Effect of prednisone on response to influenza virus vaccine in asthmatic children
6
Regional Anesthesia & Pain Medicine. Multisociety multispecialty position statement on corticosteroid injections and influenza and COVID-19 vaccine administration – Section: Influenza vaccine
7
PubMed Central. Joint Corticosteroid Injection Associated With Increased Influenza Risk
8
PubMed Central. Expert Opinion Recommendations and Guidance for Steroid Injection Therapy and COVID-19 Vaccine Administration from the American Society of Pain and Neuroscience (ASPN)
9
PubMed Central. Effect of Corticosteroid on Immunogenicity of SARS-CoV-2 Vaccines in Patients With Solid Cancer
10
Regional Anesthesia & Pain Medicine. Multisociety multispecialty position statement on corticosteroid injections and influenza and COVID-19 vaccine administration – Section: Summary and recommendations on COVID-19 vaccine